Biogen Inc. buy Needham & Company LLC
Start price
13.02.24
/
50%
€220.60
Target price
13.02.25
€284.87
Performance (%)
-11.47%
Price
26.04.24
€195.30
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.47%. This prediction currently runs until 13.02.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 7.014% | 7.014% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $305.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat